BioSpace News Archive

The International Centre for Missing and Exploited Children’s Global Missing Child Network Recognizes 25 May as a day where we remember the children that are still missing, commemorate the children who have been recovered and celebrate those that are safely back home.

John Driscoll, an executive with the nonprofit Hazelden Betty Ford Foundation, is the new board chair for the National Association of Addiction Treatment Providers.

Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood.

Amprion today announced its proprietary technology, Protein Misfolding Cyclic Amplification (PMCA) using CSF and plasma alpha-Synuclein (αS) to aid in the diagnosis of Parkinson’s disease, received a Breakthrough Device designation from U.S. FDA.

George A. Swisshelm, who fought to liberate Europe from Nazi occupation and then helped combat the spread of communism during the Korean War, will help U.S. military personnel long after his death.

PPG (NYSE: PPG) today launched its Paints with Purpose campaign, which will showcase the many unexpected applications of next-generation paint and coatings technologies.

Today, the U.S. Food and Drug Administration permitted marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint infection (infection around a joint replacement) in the synovial (lubricant) fluid of patients being evaluated for revision surgery, which is surgery performed to replace or compensate for a failed implant.

Oppenheimer & Co. Inc. (“Oppenheimer”) – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its first MedTech Day on May 29, 2019 at the Hilton Union Square in San Francisco, CA

The International Technology Law Association (ITechLaw) has published Responsible AI: A Global Policy Framework, a new book that provides an in-depth review and eight discussion principles that address some of the hottest technology and moral issues of responsible development, deployment and use of artificial intelligence.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, at 10 AM (Eastern Time), in New York, NY.